000 | 01036 a2200277 4500 | ||
---|---|---|---|
005 | 20250514205937.0 | ||
264 | 0 | _c20050113 | |
008 | 200501s 0 0 eng d | ||
022 | _a0392-856X | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAmital, H | |
245 | 0 | 0 |
_aTherapeutic approaches to familial Mediterranean fever. What do we know and where are we going to? _h[electronic resource] |
260 |
_bClinical and experimental rheumatology _c |
||
300 |
_aS4-7 p. _bdigital |
||
500 | _aPublication Type: Editorial | ||
650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
650 | 0 | 4 | _aBone Marrow Transplantation |
650 | 0 | 4 |
_aColchicine _xtherapeutic use |
650 | 0 | 4 |
_aFamilial Mediterranean Fever _xtherapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInterferon-alpha _xtherapeutic use |
650 | 0 | 4 |
_aThalidomide _xtherapeutic use |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
700 | 1 | _aBen-Chetrit, E | |
773 | 0 |
_tClinical and experimental rheumatology _gvol. 22 _gno. 4 Suppl 34 _gp. S4-7 |
|
999 |
_c15204162 _d15204162 |